Patent Assignment
Reel/Frame 062869/0213
Assignment of Assignor's Interest
Recorded: 2023-03-03
Pages: 3
Assignor
AVISTA PHARMA SOLUTIONS, INC., D/B/A CAMBREX
Executed: 2021-03-03
Assignee
IKENA ONCOLOGY, INC.
645 SUMMER STREET, SUITE 101, BOSTON, MASSACHUSETTS, 02210
Covered Property
(1)
SOLID FORMS OF (R)-N-(2-(5-FLUOROPYRIDIN-3-YL)-8-ISOPROPYLPYRAZOLO[1,5-a][1,3,5]TRIAZIN-4-YL)-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-3-AMINE AS ARYL HYDROCARBON RECEPTOR (AHR) INHIBITORS
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 3, 2023
From: CASTRO, ALFREDO C.; NOLAN, JAMES MARTIN, III
To: IKENA ONCOLOGY, INC.
Reel/Frame 062867/0175 →
Assignment of Assignor's Interest
Mar 3, 2023
From: BETHUNE, SARAH JEAN; FOLBERTH, CORINNE MARIE
To: AVISTA PHARMA SOLUTIONS, INC., D/B/A CAMBREX
Reel/Frame 062867/0523 →
Assignment of Assignor's Interest
Apr 22, 2025
From: IKENA ONCOLOGY, INC.
To: PAHR THERAPEUTICS, INC.
Reel/Frame 070907/0364 →